Oxford researchers identify anti-IL-10 autoantibodies in subset of IBD patients
Researchers from the University of Oxford, Newcastle University, and the University of Cambridge have identified autoantibodies against interleukin-10 (IL-10) in approximately 3.5% of inflammatory bowel disease (IBD) patients, offering a…